ABO and fetal erythroblastosis: In the USA, the prevalence of any HDFN was estimated to be 1,695 per 100,000 live births, with ABO and Rh alloimmunization accounting for 78.1% and 4.3% of cases, respectively, in addition to other antigens (17.6%) [42].